These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30527766)

  • 1. Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis.
    Akioyamen LE; Genest J; Chu A; Inibhunu H; Ko DT; Tu JV
    J Clin Lipidol; 2019; 13(1):15-30. PubMed ID: 30527766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis.
    Oosterveer DM; Versmissen J; Yazdanpanah M; Hamza TH; Sijbrands EJ
    Atherosclerosis; 2009 Dec; 207(2):311-7. PubMed ID: 19439299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease in familial hypercholesterolemia: Validation and refinement of the Montreal-FH-SCORE.
    Paquette M; Brisson D; Dufour R; Khoury É; Gaudet D; Baass A
    J Clin Lipidol; 2017; 11(5):1161-1167.e3. PubMed ID: 28801029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
    Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK
    Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
    Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.
    Pérez-Calahorra S; Sánchez-Hernández RM; Plana N; Marco-Benedi V; Pedro-Botet J; Almagro F; Brea A; Ascaso JF; Lahoz C; Civeira F;
    Am J Cardiol; 2017 Mar; 119(5):742-748. PubMed ID: 28081939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis.
    Akioyamen LE; Genest J; Shan SD; Reel RL; Albaum JM; Chu A; Tu JV
    BMJ Open; 2017 Sep; 7(9):e016461. PubMed ID: 28864697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort.
    Allard MD; Saeedi R; Yousefi M; Frohlich J
    Lipids Health Dis; 2014 Apr; 13():65. PubMed ID: 24712315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia.
    Paquette M; Bernard S; Ruel I; Blank DW; Genest J; Baass A
    J Clin Lipidol; 2019; 13(1):123-128. PubMed ID: 30318454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia.
    Holmes DT; Schick BA; Humphries KH; Frohlich J
    Clin Chem; 2005 Nov; 51(11):2067-73. PubMed ID: 16141286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.
    Jansen AC; van Aalst-Cohen ES; Tanck MW; Trip MD; Lansberg PJ; Liem AH; van Lennep HW; Sijbrands EJ; Kastelein JJ
    J Intern Med; 2004 Dec; 256(6):482-90. PubMed ID: 15554949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.
    Beheshti SO; Madsen CM; Varbo A; Nordestgaard BG
    J Am Coll Cardiol; 2020 May; 75(20):2553-2566. PubMed ID: 32439005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia.
    Paquette M; Dufour R; Baass A
    J Clin Lipidol; 2017; 11(1):80-86. PubMed ID: 28391914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E genotype is not associated with cardiovascular disease in heterozygous subjects with familial hypercholesterolemia.
    Mozas P; Castillo S; Reyes G; Tejedor D; Civeira F; García-Alvarez I; Puzo J; Cenarro A; Alonso R; Mata P; Pocoví M;
    Am Heart J; 2003 Jun; 145(6):999-1005. PubMed ID: 12796755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
    Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia.
    Paquette M; Chong M; Thériault S; Dufour R; Paré G; Baass A
    J Clin Lipidol; 2017; 11(3):725-732.e5. PubMed ID: 28456682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature.
    Wong B; Kruse G; Kutikova L; Ray KK; Mata P; Bruckert E
    Clin Ther; 2016 Jul; 38(7):1696-709. PubMed ID: 27261205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities with Familial Hypercholesterolemia (FH): A Systematic Review.
    Vaseghi G; Javanmard SH; Heshmat-Ghahdarijani K; Sarrafzadegan N; Amerizadeh A
    Curr Probl Cardiol; 2023 May; 48(5):101109. PubMed ID: 35007640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
    Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.